<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>University of Tehran</PublisherName>
				<JournalTitle>Journal of Sciences, Islamic Republic of Iran</JournalTitle>
				<Issn>1016-1104</Issn>
				<Volume>26</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Synthesis and Evaluation of Ethyl 2,4-dioxo-4-arylbutanoate Derivatives as Src Kinase Inhibitors</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>321</FirstPage>
			<LastPage>325</LastPage>
			<ELocationID EIdType="pii">55999</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>T.</FirstName>
					<LastName>Akbarzadeh</LastName>
<Affiliation>1 Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran</Affiliation>

</Author>
<Author>
					<FirstName>A.</FirstName>
					<LastName>Rafinejad</LastName>
<Affiliation>1 Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran</Affiliation>

</Author>
<Author>
					<FirstName>A.</FirstName>
					<LastName>Fallah-Tafti</LastName>
<Affiliation>1 Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran</Affiliation>

</Author>
<Author>
					<FirstName>R.</FirstName>
					<LastName>Tiwari</LastName>
<Affiliation>2 Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA</Affiliation>

</Author>
<Author>
					<FirstName>A.</FirstName>
					<LastName>Nasrolahi Shirazi</LastName>
<Affiliation>2 Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA</Affiliation>

</Author>
<Author>
					<FirstName>D.</FirstName>
					<LastName>Mandal</LastName>
<Affiliation>2 Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA</Affiliation>

</Author>
<Author>
					<FirstName>K.</FirstName>
					<LastName>Parang</LastName>
<Affiliation>2 Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA</Affiliation>

</Author>
<Author>
					<FirstName>A.</FirstName>
					<LastName>Foroumadi</LastName>
<Affiliation>3 Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Research Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>07</Month>
					<Day>22</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span&gt;In this work, different ethyl 2,4-dioxo-4-arylbutanoate derivatives were prepared and evaluated for their Src Kinase inhibitory activity. For this purpose, the appropriate substituted acetophenone derivatives reacted with diethyl oxalate in the presence of sodium ethoxide in dried ethanol to give the corresponding products. All compounds showed moderate activities comparing with staurosporine as the reference drug. &lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Ethyl 2,4-dioxo-4-arylbutanoates</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Src kinase</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">cancer</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jsciences.ut.ac.ir/article_55999_438a64a1dae5907a2b6f80bb64301ead.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
